D
Zevra Therapeutics, Inc. ZVRA
$8.31 $0.374.66%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -79.67% -220.49% -674.39% -25.76% -445.95%
Total Depreciation and Amortization 109.40% 2,508.06% 1,902.56% 1,877.22% 162.33%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 312.79% 758.94% 473.55% -145.66% 139.21%
Change in Net Operating Assets -89.41% -103.08% 77.25% -102.12% -172.89%
Cash from Operations -0.57% -291.98% -119.54% -299.63% -262.12%
Capital Expenditure -- -- -- -- -111.76%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -113.33% 29.20% -100.38% 184.41% 141,679.31%
Cash from Investing -151.69% 29.47% -100.38% 184.27% 16,901.59%
Total Debt Issued -100.00% -100.00% 5,160.25% -- --
Total Debt Repaid 100.00% -100.00% -11,981.51% -- -992.61%
Issuance of Common Stock -86.96% 122,098.11% 189.16% -- 5,552.78%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -84.09% 146.64% 1,511.99% 132.45% 2,047.08%
Foreign Exchange rate Adjustments 92.26% -381.37% 219.03% -169.23% 84.66%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -9,106.36% 164.46% -113.80% 99.21% 95.21%
Weiss Ratings